Primary care management consulting for GP practices and PCNs across England. IGPM Accredited Member.
Primary care consulting for GP practices & PCNs across England. Get in touch →
Cases of iatrogenic botulism have been reported following the therapeutic or cosmetic use of botulinum toxin containing products where the toxin’s effect extends beyond the area of treatment. Botulism caused by botulinum toxin is rare but can be life threatening. Symptoms can take up to four weeks to develop and may typically include difficulty breathing [...]
The post MHRA Drug Safety Update: Botulinum toxin type A products appeared first on Community Pharmacy England.
Register your practice for free to bring QOF, workforce, access, finance, contract and CQC data into a single live dashboard — benchmarked to national figures with an at-a-glance health score.